15854180

Source:http://linkedlifedata.com/resource/pubmed/id/15854180

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:15854180	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:15854180	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:15854180	lifeskim:mentions	umls-concept:C0524909	lld:lifeskim
pubmed-article:15854180	lifeskim:mentions	umls-concept:C0178602	lld:lifeskim
pubmed-article:15854180	lifeskim:mentions	umls-concept:C0036043	lld:lifeskim
pubmed-article:15854180	lifeskim:mentions	umls-concept:C0457454	lld:lifeskim
pubmed-article:15854180	lifeskim:mentions	umls-concept:C0796545	lld:lifeskim
pubmed-article:15854180	lifeskim:mentions	umls-concept:C0683956	lld:lifeskim
pubmed-article:15854180	lifeskim:mentions	umls-concept:C0301630	lld:lifeskim
pubmed-article:15854180	lifeskim:mentions	umls-concept:C1444662	lld:lifeskim
pubmed-article:15854180	pubmed:issue	9	lld:pubmed
pubmed-article:15854180	pubmed:dateCreated	2005-4-27	lld:pubmed
pubmed-article:15854180	pubmed:abstractText	Treatment with interferon-alpha has been shown to be effective in one-third of hepatitis B e antigen-positive chronic hepatitis B patients, but is clinically associated with relevant adverse events.	lld:pubmed
pubmed-article:15854180	pubmed:language	eng	lld:pubmed
pubmed-article:15854180	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15854180	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:15854180	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15854180	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15854180	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15854180	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15854180	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15854180	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15854180	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:15854180	pubmed:month	May	lld:pubmed
pubmed-article:15854180	pubmed:issn	0269-2813	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:SimonCC	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:SchalmS WSW	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:GerkenGG	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:ZeuzemSS	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:de ManR ARA	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:CakalogluYY	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:SenturkHH	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:HanselB CBC	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:AkarcaU SUS	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:JanssenH L...	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:van...	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:HBV 99-01...	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:FlinkH JHJ	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:VerheyEE	lld:pubmed
pubmed-article:15854180	pubmed:author	pubmed-author:SoT M KTM	lld:pubmed
pubmed-article:15854180	pubmed:issnType	Print	lld:pubmed
pubmed-article:15854180	pubmed:day	1	lld:pubmed
pubmed-article:15854180	pubmed:volume	21	lld:pubmed
pubmed-article:15854180	pubmed:owner	NLM	lld:pubmed
pubmed-article:15854180	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:15854180	pubmed:pagination	1163-71	lld:pubmed
pubmed-article:15854180	pubmed:dateRevised	2011-11-17	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:meshHeading	pubmed-meshheading:15854180...	lld:pubmed
pubmed-article:15854180	pubmed:year	2005	lld:pubmed
pubmed-article:15854180	pubmed:articleTitle	The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.	lld:pubmed
pubmed-article:15854180	pubmed:affiliation	Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.	lld:pubmed
pubmed-article:15854180	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:15854180	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:15854180	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:15854180	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:15854180	pubmed:publicationType	Multicenter Study	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15854180	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15854180	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15854180	lld:pubmed